Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females
NCT00813319 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 216
Last updated 2014-08-12
Summary
African American adolescent females seeking treatment for STIs are an underserved population at increased risk for HPV infection. While GARDASIL is an effective preventive vaccine, vaccination rates are low. Given the risk for HPV infection among this subgroup and the negative health effects associated with HPV, enhancing uptake of GARDASIL is necessary. The goal of this project is to promote GARDASIL vaccination through the development of a new multi-component, culturally-appropriate, interactive DVD.
We propose to recruit 280 unmarried African American adolescent females, 13-18 years of age, from participating clinic sites in Atlanta, Georgia. While seeking clinical services, adolescents will be contacted and invited to participate in the proposed study. Eligible adolescents will be required to provide written assent/consent prior to participation. Adolescents who are eligible and willing to participate in the project will complete a short survey on a laptop computer. The survey is designed to assess adolescents' risk taking and preventive behaviors. After they complete the survey, adolescents will be assigned at random to one of two groups. In one group, adolescents will watch a short (10 min), interactive DVD designed to promote HPV awareness and initial GARDASIL vaccination and receive a keepsake to help them remember to return to the clinic for their second and third vaccine doses. In the second group, adolescents will watch an equally short (10 min) DVD on healthy lifestyles and behaviors. All adolescents are eligible to receive the GARDASIL vaccine at participating study clinics as part of their routine standard of care.
With the help of clinic staff, participant medical records will be reviewed over a 7 month period to assess vaccination rates. Vaccination rates from adolescents who received the interactive HPV/GARDASIL awareness DVD will be compared to the group of adolescents who received the healthy lifestyles DVD. It is hypothesized that study participants receiving the interactive DVD intervention that promotes HPV awareness will have higher vaccination rates over time.
Conditions
- Vaccination
Interventions
- BEHAVIORAL
-
Girls OnGuard
Using the Information-Motivation-Behavioral Skills Model (IMB) as a framework, Girls OnGuard is an interactive,culturally-appropriate, computer-delivered program design to enhance initial uptake of GARDASIL by addressing three major components: (1) information about GARDASIL; (2) motivation to obtain GARDASIL vaccination; and (3) behavioral skills to enhance self-efficacy of obtaining GARDASIL vaccination.
Sponsors & Collaborators
- collaborator INDUSTRY
-
Emory University
lead OTHER
Principal Investigators
-
Ralph J. DiClemente, PhD · Emory University Rollins School of Public Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 13 Years
- Max Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2012-11-30
- Completion
- 2014-03-31
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake
NCT03337269 ·Status: COMPLETED ·Phase: NA
-
Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County
NCT02067507 ·Status: COMPLETED ·Phase: NA
-
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors
NCT04469569 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests
NCT05536843 ·Status: UNKNOWN
-
Increasing HPV Vaccination in Community-Based Pediatric Practices
NCT03399396 ·Status: COMPLETED ·Phase: NA
-
Community Awareness, Resources and Education (CARE II): Project 3
NCT01299714 ·Status: COMPLETED
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
NCT00481767 ·Status: COMPLETED ·Phase: PHASE3
-
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
NCT04612660 ·Status: COMPLETED ·Phase: NA
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
NCT04611022 ·Status: RECRUITING ·Phase: NA
-
Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities
NCT00501189 ·Status: WITHDRAWN
-
Increasing HPV Vaccination Rates Via Educational Interventions in Schools Located Within Cedars-Sinai Catchment Areas
NCT03953911 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
NCT05959564 ·Status: COMPLETED ·Phase: NA
-
Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta
NCT03713710 ·Status: COMPLETED ·Phase: NA
-
Study of the Impact of a School Program Combining - Promotion of HPV Vaccination and HPV Vaccine Offer in Middle School - on Adherence to HPV Vaccination in Middle School Students
NCT04459221 ·Status: COMPLETED ·Phase: PHASE4
-
An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women
NCT02464358 ·Status: COMPLETED ·Phase: NA
-
Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls
NCT01173900 ·Status: COMPLETED ·Phase: PHASE4
-
Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda
NCT06536855 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
NCT06397378 ·Status: RECRUITING ·Phase: NA
-
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
NCT06843720 ·Status: RECRUITING ·Phase: NA
-
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
NCT01034358 ·Status: COMPLETED ·Phase: PHASE4
-
Postpartum HPV Vaccination
NCT03451071 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study
NCT05149248 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of an Mhealth Intervention to Increase Adherence to Triage of HPV+ Women
NCT02561208 ·Status: WITHDRAWN ·Phase: NA
-
FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program
NCT03105856 ·Status: COMPLETED ·Phase: PHASE4
-
Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors
NCT02046265 ·Status: COMPLETED ·Phase: NA